SF3A2 and cancer: Interestingly, and highlighting the context-dependent role of SF3A2, elevated SF3A2 expression was associated with extended OS in several other cancer types, including TGCT, CESC, PAAD, STAD, THYM, UCEC, and UVM patients (Figure 3N-T).